Eterylate (I) [62992-61-4] was prepared by coupling p-(2-hydroxyethoxy)acetanilide [50375-15-0] with o-acetoxybenzoyl chloride [5538-51-2] and tested for antiinflammatory and analgesic activities.The activities of I were similar to those of acetylsalicylic acid and benorylate in equimol. doses.The oral LD50 in mice for I, benorylate, and acetylsalicylic acid, were 3160, 1551, and 1259 mg/kg, resp.The gastrointestinal lesions observed after treatment for 30 days revealed that both I and benorylate were tolerated better than acetylsalicylic acid.Further, I had the advantage of causing less gastric lesioning and less hemorrhaging.Phys. and chem. properties of I are discussed.